Salicylate-induced bleeding problem in ophthalmic plastic surgery

Area of Science:

• Hematology
• Oncology
• Ophthalmology

Background:

• Polycythemia vera (PCV) is a myeloproliferative neoplasm characterized by increased red blood cell mass.
• Patients with PCV often have altered platelet function, increasing bleeding risk.
• Pre-operative management of PCV patients requires careful consideration of bleeding risks.

Observation:

• A 54-year-old woman with clinically asymptomatic PCV underwent elective eyelid surgery.
• Following an uncomplicated surgical procedure, the patient ingested a small dose of aspirin.
• Within 24 hours, she developed a severe bleeding diathesis.

Findings:

• Aspirin, a common antiplatelet agent, exacerbated the underlying bleeding tendency in this PCV patient.
• Salicylates significantly impair platelet aggregation, particularly in patients with pre-existing platelet dysfunction.
• The patient's bleeding disorder was successfully managed with appropriate interventions.

Implications:

• This case underscores the critical importance of assessing bleeding risks in PCV patients, even when asymptomatic.
• Physicians should exercise caution when prescribing aspirin or other salicylates to PCV patients, especially perioperatively.
• Further research into the specific mechanisms of salicylate-induced bleeding in PCV is warranted.